Note 22. Loss per Share

Basic and diluted net loss per share for the years ended December 31, 2025, 2024 and 2023, consisted of the following (in thousands, except shares and per share amounts):

​

​

As the average market price of common stock for the years ended December 31, 2025, 2024 and 2023, did not exceed the exercise price of the Warrants, the potential dilution from the Warrants converting into 14,385,500 shares of common stock for both periods have been excluded from the number of shares used in calculating diluted net loss per share as their inclusion would have been antidilutive. For the years ended December 31, 2025, 2024 and 2023, the potential dilution from unvested RSUs converting into 630,940, 449,409 and 173,333 shares of common stock, respectively, has been excluded from the number of shares used in calculating diluted net loss per share as their inclusion would have been antidilutive.